Black Diamond Therapeutics Inc.
BDTX | NASDAQ
$1.94
-$0.01 (-0.51%)
Sep 22, 2026, 12:11 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | 70M | 70M | 70M | 70M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 27K | 113K | 86K | 86K | 86K | 86K | 172K | 172K | 172K | 86K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | -27K | -113K | 69.91M | 69.91M | 69.91M | 69.91M | -172K | -172K | -172K | -86K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -51.9M | -53.27M | 12.52M | 11.86M | 4.71M | -4.01M | -78.78M | -81.36M | -87.24M | -85.15M | -86.46M | -87.46M | -85.57M | -88.71M | -92.83M | -97.06M | -110.3M | -121.84M | -126.87M | -123.98M | -107.09M | -87.4M |
Interest Income | 4.29M | 4.49M | 4.06M | 3.44M | 2.79M | 2.14M | 2.18M | 1.94M | 1.86M | 1.94M | 1.92M | 2.28M | 2.4M | 2.25M | 2.03M | 1.94M | 2.16M | 2.72M | 3.46M | 4.13M | 4.52M | 4.45M |
Pretax Income | -42.56M | -43.21M | 22.37M | 21.5M | 14.44M | 5.09M | -69.68M | -73.1M | -80.55M | -79.79M | -82.44M | -84.11M | -82.76M | -86.54M | -91.17M | -95.96M | -109.38M | -120.8M | -125.6M | -122.36M | -105.19M | -85.41M |
Net Income | -42.56M | -43.21M | 22.37M | 21.5M | 14.44M | 5.09M | -69.68M | -73.1M | -80.55M | -79.79M | -82.44M | -84.11M | -82.76M | -86.54M | -91.17M | -95.96M | -109.38M | -120.8M | -125.6M | -122.36M | -105.19M | -85.41M |
Selling & General & Admin | 16.43M | 15.86M | 16.57M | 18.58M | 20.26M | 25.73M | 27.47M | 27.06M | 29.7M | 27M | 27.11M | 28.79M | 27.21M | 27.31M | 28.39M | 27.56M | 29.03M | 30.04M | 30.04M | 29.05M | 26.87M | 23.73M |
Research & Development | 28.13M | 30.06M | 33.56M | 39.56M | 45.04M | 48.19M | 51.14M | 54.13M | 57.37M | 58.06M | 59.35M | 58.67M | 58.36M | 61.4M | 64.44M | 69.49M | 81.27M | 91.8M | 96.83M | 94.92M | 80.22M | 63.68M |
Other Expenses | 7.35M | 7.26M | 7.26M | -86K | -86K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 51.9M | 53.18M | 57.39M | 58.06M | 65.21M | 73.92M | 78.61M | 81.19M | 87.07M | 85.06M | 86.46M | 87.46M | 85.57M | 88.71M | 92.83M | 97.06M | 110.3M | 121.84M | 126.87M | 123.98M | 107.09M | 87.4M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 51.9M | 53.27M | 57.48M | 58.14M | 65.3M | 74.01M | 78.78M | 81.36M | 87.24M | 85.15M | 86.46M | 87.46M | 85.57M | 88.71M | 92.83M | 97.06M | 110.3M | 121.84M | 126.87M | 123.98M | 107.09M | 87.4M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 57.37M | 57.23M | 57.09M | 56.65M | 56.8M | 56.66M | 56.61M | 56.51M | 55.16M | 51.81M | 47.45M | 50.94M | 36.52M | 36.48M | 36.39M | 36.35M | 36.29M | 36.27M | 36.23M | 36.22M | 36.18M | 36.12M |
Shares Outstanding (Diluted) | 57.37M | 57.23M | 57.09M | 56.93M | 56.8M | 57.67M | 56.61M | 56.51M | 55.16M | 51.81M | 47.45M | 50.94M | 36.52M | 36.48M | 36.39M | 36.35M | 36.29M | 36.27M | 36.23M | 36.22M | 36.18M | 36.12M |
EPS (Basic) | -0.74 | -0.76 | 0.40 | 0.38 | 0.25 | 0.08 | -1.27 | -1.40 | -1.57 | -1.73 | -1.95 | -2.13 | -2.28 | -2.39 | -2.52 | -2.64 | -3.01 | -3.33 | -3.47 | -3.39 | -2.92 | -2.38 |
EPS (Diluted) | -0.74 | -0.76 | 0.38 | 0.36 | 0.23 | 0.06 | -1.27 | -1.40 | -1.57 | -1.73 | -1.95 | -2.13 | -2.28 | -2.39 | -2.52 | -2.64 | -3.01 | -3.33 | -3.47 | -3.39 | -2.92 | -2.38 |
EBITDA | -40.88M | -38.09M | 27.55M | 21.84M | 14.78M | 5.44M | -69.33M | -72.76M | -80.18M | -79.39M | -82.01M | -83.64M | -82.27M | -86.03M | -90.66M | -95.45M | -108.96M | -120.49M | -125.8M | -122.67M | -105.53M | -85.76M |
EBIT | -41.08M | -38.36M | 27.22M | 21.5M | 14.44M | 5.09M | -69.68M | -73.1M | -80.55M | -79.79M | -82.44M | -84.11M | -82.76M | -86.54M | -91.17M | -95.96M | -109.38M | -120.8M | -126.01M | -122.77M | -105.6M | -85.82M |
Depreciation & Amortization | 207K | 265K | 325K | 344K | 344K | 344K | 343K | 344K | 373K | 401K | 437K | 477K | 491K | 505K | 508K | 505K | 419K | 311K | 205K | 97K | 68K | 61K |
Add to Watchlist
Select watchlists to add or remove BDTX